A dose-escalation safety and immunogenicity study of a new live attenuated human rotavirus vaccine (Rotavin-M1) in Vietnamese children.

[1]  S. Gatchalian,et al.  Immunogenicity, reactogenicity and safety of the human rotavirus vaccine RIX4414 (Rotarix™) oral suspension (liquid formulation) when co-administered with expanded program on immunization (EPI) vaccines in Vietnam and the Philippines in 2006-2007. , 2011, Vaccine.

[2]  R. Glass,et al.  Inhibitory Effect of Breast Milk on Infectivity of Live Oral Rotavirus Vaccines , 2010, The Pediatric infectious disease journal.

[3]  A. Steele,et al.  Comparison of 2 different regimens for reactogenicity, safety, and immunogenicity of the live attenuated oral rotavirus vaccine RIX4414 coadministered with oral polio vaccine in South African infants. , 2010, The Journal of infectious diseases.

[4]  M. Levine,et al.  Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial , 2010, The Lancet.

[5]  T. Vesikari,et al.  Immunogenicity and safety of the human rotavirus vaccine Rotarix co-administered with routine infant vaccines following the vaccination schedules in Europe. , 2010, Vaccine.

[6]  T. C. Ngo,et al.  Molecular epidemiology of rotavirus diarrhoea among children in Haiphong, Vietnam: the emergence of G3 rotavirus. , 2009, Vaccine.

[7]  R. Glass,et al.  Development and characterization of candidate rotavirus vaccine strains derived from children with diarrhoea in Vietnam. , 2009, Vaccine.

[8]  Manish M Patel,et al.  Oral rotavirus vaccines: how well will they work where they are needed most? , 2009, The Journal of infectious diseases.

[9]  S. Taneja,et al.  A dose-escalation safety and immunogenicity study of live attenuated oral rotavirus vaccine 116E in infants: a randomized, double-blind, placebo-controlled trial. , 2009, The Journal of infectious diseases.

[10]  O. Nakagomi,et al.  A critical review on a globally-licensed, live, orally-administrable, monovalent human rotavirus vaccine: Rotarix , 2009, Expert opinion on biological therapy.

[11]  Manish M Patel,et al.  Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua. , 2009, JAMA.

[12]  D. Sack,et al.  Successful co-administration of a human rotavirus and oral poliovirus vaccines in Bangladeshi infants in a 2-dose schedule at 12 and 16 weeks of age. , 2009, Vaccine.

[13]  J. Salomon,et al.  Cost-effectiveness of Rotavirus vaccination in Vietnam , 2009, BMC public health.

[14]  P. Dennehy,et al.  Coadministration of RIX4414 Oral Human Rotavirus Vaccine Does Not Impact the Immune Response to Antigens Contained in Routine Infant Vaccines in the United States , 2008, Pediatrics.

[15]  K. Gottesdiener,et al.  Concomitant Use of the Oral Pentavalent Human-Bovine Reassortant Rotavirus Vaccine and Oral Poliovirus Vaccine , 2008, The Pediatric infectious disease journal.

[16]  C. Hart,et al.  Lack of shedding of the RIX4414 live attenuated rotavirus vaccine administered to adult volunteers , 2007, Archives of Virology.

[17]  K. T. Hoang,et al.  Diversity of viruses associated with acute gastroenteritis in children hospitalized with diarrhea in Ho Chi Minh City, Vietnam , 2007, Journal of medical virology.

[18]  R. Glass,et al.  Rotavirus vaccines: current prospects and future challenges , 2006, The Lancet.

[19]  R. Glass,et al.  The Burden of Rotavirus Diarrhea in Khanh Hoa Province, Vietnam: Baseline Assessment for a Rotavirus Vaccine Trial , 2006, The Pediatric infectious disease journal.

[20]  D. Bernstein,et al.  A rotavirus vaccine for infants: the Asian experience. , 2006, Annals of the Academy of Medicine, Singapore.

[21]  R. Glass,et al.  Epidemiological profile and burden of rotavirus diarrhea in Vietnam: 5 years of sentinel hospital surveillance, 1998-2003. , 2005, The Journal of infectious diseases.

[22]  A. Linhares,et al.  Evaluation of Safety, Immunogenicity and Efficacy of an Attenuated Rotavirus Vaccine, RIX4414: A Randomized, Placebo-Controlled Trial in Latin American Infants , 2005, The Pediatric infectious disease journal.

[23]  S. Quak,et al.  Evaluation of RIX4414, a live, attenuated rotavirus vaccine, in a randomized, double-blind, placebo-controlled phase 2 trial involving 2464 Singaporean infants. , 2005, The Journal of infectious diseases.

[24]  R. Ward,et al.  Comparative Evaluation of Safety and Immunogenicity of Two Dosages of an Oral Live Attenuated Human Rotavirus Vaccine , 2005, The Pediatric infectious disease journal.

[25]  T. Vesikari,et al.  A Rotavirus Vaccine for Prophylaxis of Infants Against Rotavirus Gastroenteritis , 2004, The Pediatric infectious disease journal.

[26]  R. Glass,et al.  Identification of group A rotavirus gene 4 types by polymerase chain reaction , 1992, Journal of clinical microbiology.